Table 3.
MBL2 genotypes and severity of fibrosis in hepatitis C virus patients.
| Stages of liver fibrosis | ||||||
|---|---|---|---|---|---|---|
| Stage F2 | Stage F3 | Stage F4 | ||||
| MBL2 genotype | (n = 21) | % | (n = 36) | % | (n = 45) | % |
| YA/YA | 7 | 33·3 | 10 | 27·8 | 13 | 28·9 |
| XA/YA | 4 | 19·1 | 8 | 22·2 | 11 | 24·4 |
| YA/YA + XA/YA | 11 | 52·4 | 18 | 50·0 | 24 | 53·3 |
| YA/YO | 4 | 19·1 | 11 | 30·6 | 17 | 37·8 |
| XA/XA | 2 | 9·5 | 3 | 8·3 | 1 | 2·2 |
| XA/YO | 3 | 14·3 | 3 | 8·3 | 3 | 6·7 |
| YO/YO | 1 | 4·7 | 1 | 2·8 | 0 | 0 |
| XA/XA + XA/YO + YO/YO | 6 | 28·6 | 7 | 19·4 | 4 | 8·9 |
n, number of individuals. Bold type, significant difference (P = 0·04, odds ratio 0·24 confidence interval 95% 0·06–0·99).